Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 17, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

Glioblastoma Multiforme

Interventions

DEVICE

Oncomagnetic device

OncoMAGNETX has developed a portable wearable noninvasive magnetic device (Oncomagnetic device) for the treatment of GBM.

Trial Locations (6)

RECRUITING

Clinical Center Lünen, Lünen

RECRUITING

University Hospital Bonn, Bonn

RECRUITING

Medical Center Mannheim, Mannheim

RECRUITING

Clinical Center Stuttgart, Stuttgart

RECRUITING

Technical University of Munich, München

RECRUITING

University Hospital Leipzig, Leipzig

All Listed Sponsors

lead

BioTex, Inc.

INDUSTRY